Step by Step


11/1/2016 - Medical Grand Rounds: COPD Year in Review





Credit Hours: CME 1.00

Target Audience:

Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Recognize that lung function attained early in adulthood may impact the development of COPD later in life and that a wide range of lung function trajectories exist.
  • Appreciate that current and former smokers with symptoms but preserved pulmonary function have respiratory exacerbations, shorter walk distance, and evidence of subtle airway disease.
  • Describe the impact of a health coaching intervention on COPD readmission rates and outcomes
  • Describe how recent literature supports a clinical precision approach to selecting patients for bronchoscopic volume reduction.
  • Recognize that only a subset of COPD patients benefit from inhaled corticosteroids and to begin to select appropriate patients for treatment.

Suggested Additional Reading:

  1. Lange P et al. N Engl J Med 2015;373:111-122.
  2. Woodruff PG et al. N Engl J Med 2016;374:1811-1821.
  3. Mannino et al, Resp Med, Jan 2006.
  4. Shah et al. Chest 2015;147(5).
  5. Benzo et al. AJRCCM 2016; 194(6).
  6. Roberto Benzo; Kristin Vickers; Paul J. Novotny; Sharon Tucker; Johanna Hoult; Pamela Neuenfeldt; John Connett; Kate Lorig; Charlene McEvoy; Am J Respir Crit Care Med  194, 672-680. DOI: 10.1164/rccm.201512-2503OC.
  7. Magnussen et. al. NEJM 2014; 371:1285-1294.
  8. Watz et. al. The Lancet Respiratory Medicine 2016; 5:390–398.

Frank C. Sciurba, MD, FCCP — Associate Professor of Medicine Division of Pulmonary, Allergy and Critical Care Medicine Director, Emphysema Research Center Director, Pulmonary Function Exercise Physiology Laboratory
Dr. Sciurba receives grant/research support from Boehringer-Ingelheim Pharmaceuticals, Inc, GlaxoSmithKline, PneumRX, Inc., PulmonX. Dr. Sciurba is a consultant Boehringer-Ingelheim Pharmaceuticals, Inc., and GlaxoSmithKline.
Jessica Bon Field, MD, MS — Associate Program Director of Research, Internal Medicine Residency Director, Research Pathway Track Assistant Professor of Medicine Division of Pulmonary, Allergy and Critical Care Medicine
Dr. Bon receives grant/research support from Astra Zeneca.
Authors disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above. No other planners, members of the planning committee, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits. Each physician should only claim credit commensurate with the extent of their participation in the activity.

The University of Pittsburgh is an affirmative action, equal opportunity institution.